Investment Stage

Focus Areas

About Investor

Alexander Hall-Daniels is a Principal at IndieBio NY (SOSV), based in New York. He backs companies “saving lives or the planet,” with a focus across deep science in human and planetary health (biotech, therapeutics, diagnostics, climate, ag, food, and materials), typically starting at pre-seed and supporting companies through later rounds. IndieBio’s program writes up to $525,000 at the start, and it typically invests an additional $250k–$500k in the next qualified priced round to maintain its ownership target. Background-wise, he joined SOSV in 2018 via RebelBio in London and previously worked in Edelman’s pharmaceutical practice and at an early-stage consultancy startup. Investing in companies saving lives or the planet.